Skip to main content
Clinical Trials/NCT06656429
NCT06656429
Completed
Not Applicable

Outcome of Transforminal Epidural Injections in Patients with Lumbar Radicular Pain

Muhammad Aamir Latif1 site in 1 country62 target enrollmentOctober 1, 2021

Overview

Phase
Not Applicable
Intervention
Transforaminal Epidural Steroid Injections
Conditions
Lumbar Redicular Pain
Sponsor
Muhammad Aamir Latif
Enrollment
62
Locations
1
Primary Endpoint
Pain score
Status
Completed
Last Updated
last year

Overview

Brief Summary

Back pain is the most common chronic pain disorder of adult population. Lumbar radicular pain occurs due to irritation or compression of the nerve roots in the lower back. Various non-surgical methods can also be exercised that have been used to treat lumbar radicular pain since the ancient times. Despite the availability of various treatment options, achieving optimal pain relief and functional recovery remains challenging. Lumbar Transforaminal Epidural Steroid Injections (TFESI) are commonly used to manage this condition, but there is variability in patient response and limited data on the effectiveness of TFESI in different demographic and clinical subgroups.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
September 30, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Muhammad Aamir Latif
Responsible Party
Sponsor Investigator
Principal Investigator

Muhammad Aamir Latif

Consultant

RESnTEC, Institute of Research

Eligibility Criteria

Inclusion Criteria

  • Both genders
  • Aged between 45 and 80 years
  • Experiencing lumbar radicular pain

Exclusion Criteria

  • History of spinal fracture or previous spinal surgery
  • Recurrent pain within 3 months of prior treatment
  • Ongoing steroid therapy
  • IKnown allergy to dexamethasone or lidocaine

Arms & Interventions

TFESI

Lumbar Transforaminal Epidural Steroid Injections was administered, consisting of 4 mg dexamethasone and 0.33% lidocaine in a 3 ml solution.

Intervention: Transforaminal Epidural Steroid Injections

Outcomes

Primary Outcomes

Pain score

Time Frame: 4-week

Patients were monitored for four weeks post-treatment, with follow-up visits scheduled at 1 week and 4 weeks. Pain scores were reassessed using visual analog scale (scores between 1 to 10). Lower scores meant lower pain whereas higher scores meant higher degree of pain

Study Sites (1)

Loading locations...

Similar Trials